InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.040
-0.050 (-4.59%)
At close: Jan 9, 2026, 4:00 PM EST
1.090
+0.050 (4.81%)
After-hours: Jan 9, 2026, 7:56 PM EST
InflaRx Market Cap
InflaRx has a market cap or net worth of $70.46 million as of January 9, 2026. Its market cap has decreased by -52.14% in one year.
Market Cap
70.46M
Enterprise Value
19.53M
1-Year Change
-52.14%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $70.46M, a decrease of -79.92%. That is a compound annual growth rate of -17.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 70.50M | 3.07% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.01B |
| Johnson & Johnson | 495.52B |
| AbbVie | 397.03B |
| UnitedHealth Group | 314.28B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.11B |
| Merck & Co. | 272.67B |
| Novo Nordisk | 254.60B |